Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)

Name: Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)
Published: 2016
License: Public Domain

Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

follicular low grade non-hodgkin's lymphoma, follicular lymphoma, fl, low-grade lymphoma, non-hodgkin's lymphoma, follicular nhl, marginal zone, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)

Related documents